RT Journal Article
SR Electronic
T1 Accuracy of Rapid Antigen Testing across SARS-CoV-2 Variants
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.21.22272279
DO 10.1101/2022.03.21.22272279
A1 Drain, Paul K.
A1 Bemer, Meagan
A1 Morton, Jennifer F.
A1 Dalmat, Ronit
A1 Abdille, Hussein
A1 Thomas, Katherine
A1 Uppal, Timsy
A1 Hau, Derrick
A1 Green, Heather R.
A1 Gates-Hollingworth, Marcellene A.
A1 AuCoin, David P.
A1 Verma, Subhash C.
YR 2022
UL http://medrxiv.org/content/early/2022/03/23/2022.03.21.22272279.abstract
AB Variants of SARS-CoV-2 have mutations in the viral genome that may alter the accuracy of rapid diagnostic tests. We conducted analytical and clinical accuracy studies of two FDA-approved rapid antigen tests—SCoV-2 Ag Detect™ Rapid Test (InBios International, Seattle) and BinaxNOW™ COVID-19 Ag CARD; (Abbott Laboratories, Chicago)—using three using replication-competent variants or strains, including Omicron (B.1.1.529/BA.1), Delta (B.1.617.2), and a wild-type of SARS-CoV-2 (USA-WA1/2020). Overall, we found non-significant differences in the analytical limit of detection or clinical diagnostic accuracy of rapid antigen testing across SARS-CoV-2 variants. This study provides analytical and clinical performance data to demonstrate the preserved accuracy of rapid antigen testing across SARS-CoV-2 variants among symptomatic adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the US Department of Defense.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the University of Wasington gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript